GEMTESA®

Drug Information Related Patent

Hold Company

UROVANT

Dosage and Administration

TABLET;ORAL

Specification

75MG

Indication

GEMTESA® can be used to treat overactive bladder (OAB) in adults with urge urinary incontinence and frequent urination.

Use

Instructions for Use

API

VIBEGRON

API Structure

We Supply

Note:

null

Note:

null

Note:

null

Drug Patent

Patent No	Expiration Date
8247415	2030/12/1
8653260	2029/4/2

API Patent

Patent No	Expiration Date
8247415	2030/12/1
8653260	2029/4/2

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION

Member of